Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought
Illumina Q1 2025 Earnings Preview
Trump Planning on Executive Order to Further Cut Medicare Drug Prices - Report
What the Options Market Tells Us About Amgen
MHRA Approves Teprotumumab As The First UK Treatment For Adults With Moderate To Severe Thyroid Eye Disease
Preview: Natera's Earnings
Forecasting The Future: 7 Analyst Projections For Amgen
Price Over Earnings Overview: Regeneron Pharmaceuticals
Biogen Analyst Ratings
Amgen Analyst Ratings
Natera's Prospera Heart With DQS Cuts False Positives By Over 37%, Outperforming Dd-cfDNA Percentage Alone, AJT Publication Shows
Trump wants to impose tariffs on Pharmaceuticals: Pharmaceutical companies are busy stockpiling, and the import volume in the USA surged in March.
① The volume of Pharmaceutical imports in the USA surged in March, as pharmaceutical companies stockpiled products in anticipation of potential tariffs; ② A report released by the US Department of Commerce on Tuesday showed that the total value of Pharmaceutical imports in March exceeded 50 billion USD, equivalent to 20% of the total Pharmaceutical imports for the entire year of 2024.
Trump Administration Cancels Meeting With FDA Workers Union - Report
Neurocrine Biosciences' Ingrezza Q1 Sales Prove Resilient, Analysts Boost Price Target
SA Analyst Upgrades: AMD, MPW, LYV, TGTX
Guggenheim Maintains Buy on Neurocrine Biosciences, Raises Price Target to $165
FARO Technologies, Celanese, Avient, Aramark And Other Big Stocks Moving Higher On Tuesday
Neurocrine Biosciences Analyst Ratings
Needham Maintains Buy on BioCryst Pharma, Raises Price Target to $17
BioCryst Pharma Analyst Ratings